Nichols CD
Department of Pharmacology and Experimental Therapeutics, Louisiana State University Health Sciences Center, New Orleans, LA, USA. cnich1@lsuhsc.edu.
ArticlePsychedelics
Psychedelic research must be grounded in pharmacology.
ArticlePsilocybin
Psychedelics produce enduring behavioral effects and functional plasticity through mechanisms independent of structural plasticity.
ArticlePsilocybin
The Selective Serotonin 5‑HT<sub>2A</sub> Receptor Agonist (<i>S</i>)‑3-(2,5-Dimethoxy-4-(trifluoromethyl)phenyl)piperidine (LPH-5) Induces Persistent and Robust Antidepressant-Like Effects in Rodents.
ArticlePsilocybin
5-HT<sub>2A</sub> receptors: Pharmacology and functional selectivity.
ArticleMescaline
History of psychedelic drug science and molecular pharmacology.
PreprintPsilocybin
The selective 5-HT <sub>2A</sub> receptor agonist LPH-5 induces persistent and robust antidepressant-like effects in rodents
ArticlePsilocybin
Preadministration of Lorazepam Reduces Efficacy and Longevity of Antidepressant-Like Effect from a Psychedelic.
ArticlePsychedelics
If Everything Is Psychedelic, Then Nothing Is: A Response to O'Donnell et al. and Lepow et al.
ArticleDMT
5-MeO-DMT: An atypical psychedelic with unique pharmacology, phenomenology & risk?
ArticlePsychedelics
The Elephant in the Room: Personal Use of Psychedelics Among Psychedelic Researchers.
ArticleKetamine
Psychedelic Commercialization: A Wide-Spanning Overview of the Emerging Psychedelic Industry.
ArticlePsychedelics
Proposed Consensus Statement on Defining Psychedelic Drugs.
ArticlePsychedelics
Past, Present, and Future of Psychedelics: A <i>Psychedelic Medicine</i> Roundtable Discussion.
ArticlePsilocybin
A Single Administration of Psilocybin Persistently Rescues Cognitive Deficits Caused by Adolescent Chronic Restraint Stress Without Long-Term Changes in Synaptic Protein Gene Expression in a Rat Experimental System with Translational Relevance to Depression.
ArticlePsychedelics
Editors' Introduction to <i>Psychedelic Medicine</i>.
ArticlePsilocybin
Preclinical perspectives on the mechanisms underlying the therapeutic actions of psilocybin in psychiatric disorders.
ArticlePsilocybin
Psychedelic drug abuse potential assessment research for new drug applications and Controlled Substances Act scheduling.
ArticlePsilocybin
Validation of the forced swim test in Drosophila, and its use to demonstrate psilocybin has long-lasting antidepressant-like effects in flies.
ArticleLSD
Lysergic acid diethylamide induces increased signalling entropy in rats' prefrontal cortex.
PreprintLSD
LSD induces increased signalling entropy in rats’ prefrontal cortex
ArticlePsychedelics
Structure-Activity Relationship Analysis of Psychedelics in a Rat Model of Asthma Reveals the Anti-Inflammatory Pharmacophore.
ArticleKetamine
Psychedelics, but Not Ketamine, Produce Persistent Antidepressant-like Effects in a Rodent Experimental System for the Study of Depression.
ArticlePsilocybin
Population Survey Data Informing the Therapeutic Potential of Classic and Novel Phenethylamine, Tryptamine, and Lysergamide Psychedelics.
ArticleLSD
Safety, tolerability, pharmacokinetics, and pharmacodynamics of low dose lysergic acid diethylamide (LSD) in healthy older volunteers.
ArticlePsilocybin
Microdosing psychedelics: More questions than answers? An overview and suggestions for future research.
ArticlePsilocybin